4th Report - Medicines security—a national priority
- HC No.
- —
- Published
- 4 Feb 2026
- Items
- 0
- Response
- Response document linked Read government response ↗
Select Committee · Public Services Committee
Medicines security
Status: Open
Opened: 5 Aug 2025
1 report
Inquiry scope
Medicine shortages across England are increasing, which in turn impacts the health of patients, and puts significant pressure on the NHS, Pharmacies and GPs. The aim of this inquiry is to understand the causes of medicine shortages, and understand the UK's capabilities in predicting and preventing medicine supply issues, and minimising patient harms. Read the key points in our enhanced report summaryReports
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 10 Dec 2025 |
Evidence Session 7 - Dr Zubir Ahmed and David Simmons (Uncorrected)
David Simmons · Department of Health and Social Care (DHSC),
Dr Zubir Ahmed MP · Department of Health and Social Care (DHSC)
|
View ↗ |
| 12 Nov 2025 | Darius Hughes · Moderna, David Watson · The Association of the British Pharmaceutical Industry (ABPI), Dr Martin Turner · Bioindustry Association, Ian Wariner · Orion Pharma (UK), Mark Samuels · British Generic Manufacturers Association (BGMA), Paul White · Besins Healthcare UK Limited | View ↗ |
| 5 Nov 2025 | Amandeep Doll · Royal Pharmaceutical Society, James Davies · Community Pharmacy England, Malcolm Harrison · Company Chemists' Association, Martin Sawer · Healthcare Distribution Association (HDA), Mr Andrew Davies · NHS England, Mr Richard Bowers · Leeds Teaching Hospitals NHS Trust | View ↗ |
| 22 Oct 2025 | Andrew Howard · Schroders, Claire Foreman · NHS England, David Simmons · Department of Health and Social Care (DHSC) | View ↗ |
| 15 Oct 2025 | Dr Emilia Vann Yaroson, Dr Keith Ridge, Dr Paul-Enguerrand Fady · The Centre for Long Term Resilience (CLTR) | View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| David Simmons · Director for Supply Resilience and Medicines | Department of Health and Social Care (DHSC) | 2 |
| Amandeep Doll · Director for England | Royal Pharmaceutical Society | 1 |
| Andrew Howard · Global Head of Sustainable Investment | Schroders | 1 |
| Claire Foreman · Director of Medicine Policy and Strategy | NHS England | 1 |
| Darius Hughes · UK General Manager | Moderna | 1 |
| David Watson · Executive Director of Economic, Health and Commercial Policy | The Association of the British Pharmaceutical Industry (ABPI) | 1 |
| Dr Emilia Vann Yaroson | — | 1 |
| Dr Keith Ridge | — | 1 |
| Dr Martin Turner · Director of Policy and External Affairs | Bioindustry Association | 1 |
| Dr Paul-Enguerrand Fady · Bio Security Manager | The Centre for Long Term Resilience (CLTR) | 1 |
| Dr Zubir Ahmed MP · Parliamentary Under-Secretary of State | Department of Health and Social Care (DHSC) | 1 |
| Ian Wariner · Country Manager | Orion Pharma (UK) | 1 |
| James Davies · Director of Research and Insights | Community Pharmacy England | 1 |
| Malcolm Harrison · Chief Executive | Company Chemists' Association | 1 |
| Mark Samuels · CEO | British Generic Manufacturers Association (BGMA) | 1 |
| Martin Sawer · Executive Director | Healthcare Distribution Association (HDA) | 1 |
| Mr Andrew Davies · Former National Director of Hospital Pharmacy | NHS England | 1 |
| Mr Richard Bowers · Medicines Procurement and Supply | Leeds Teaching Hospitals NHS Trust | 1 |
| Paul White · Head of Legal | Besins Healthcare UK Limited | 1 |
Correspondence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
Meetings & visits
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Type | Detail | Source |
|---|---|---|---|
| 21 Jan 2026 | Formal meeting (private meeting) | — · Room 3A, Palace of Westminster | |
| 14 Jan 2026 | Formal meeting (private meeting) | — · Room 2A, Palace of Westminster | |
| 19 Nov 2025 | Formal meeting (private meeting) | — · Room 4A, Palace of Westminster |